~~<i id='909395A5A9'><strike id='909395A5A9'><tt id='909395A5A9'><pre id='909395A5A9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：knowledge 2025-08-31 21:01:06 - browse：962

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： How to use technology to prevent future drug shortages

hotspot

explore

focus

knowledge

focus

hotspot

TheFDAislookingintoadverseeventsinvolvinganumberofCAR-Ttherapies,includingBreyanzi.Illustration:STAT

WSS

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Wegovy trial has doctors encouraged over new possibilities

J&J to emphasize cancer drugs, stop much of its vaccine research

The best solution to the drug shortages problem

Friends ask where James Watson's attitudes about race came from

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

focus

entertainment

hotspot

Jerome Adams on the need for new antivirals for Covid

The best solution to the drug shortages problem

Moonlake's readout produced a cash windfall. Risks remain

Naloxone nonprofit donates 200,000 doses after FDA approval

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How to pay for weight loss drugs and save Medicare

Activists slam private health insurers over coverage restrictions

Police still searching for prisoner who escaped from NYC hospital

Medical leaders decry Supreme Court decision on affirmative action

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

explore

The best solution to the drug shortages problem

A biotech analyst on neuroscience, placebo effect, not over

What to know about Virgin Galactic's 1st mission taking paying customers to space

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

NIH trials fail to test meaningful long Covid therapies, experts say

In same hospitals, Black patients receive fewer opioids than white patients

focus

knowledge

focus

hotspot